Spots Global Cancer Trial Database for basal cell cancer
Every month we try and update this database with for basal cell cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) | NCT04928222 | Basal Cell Carc... | Doxorubicin-con... Placebo-contain... | 18 Years - 75 Years | SkinJect, Inc. | |
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma | NCT04552990 | BCC BCC - Basal Cel... Basal Cell Carc... Basal Cell Canc... Superficial Bas... Nodular Basal C... | Jet injection o... Surgical excisi... Illumination Incubation | 18 Years - | Memorial Sloan Kettering Cancer Center | |
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors | NCT06398418 | Melanoma Basal Cell Carc... Squamous Cell C... Melanoma Recurr... Basal Cell Canc... Squamous Cell C... | R-5780 | 18 Years - 80 Years | Rise Therapeutics LLC | |
Using MC1R Genotype to Impact Melanoma Risk Behavior | NCT03509467 | Melanoma (Skin) Squamous Cell C... Squamous Cell C... Skin Cancer Basal Cell Carc... Basal Cell Canc... | Personalized In... Standard Inform... DNA Extraction ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Using MC1R Genotype to Impact Melanoma Risk Behavior | NCT03509467 | Melanoma (Skin) Squamous Cell C... Squamous Cell C... Skin Cancer Basal Cell Carc... Basal Cell Canc... | Personalized In... Standard Inform... DNA Extraction ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) | NCT04928222 | Basal Cell Carc... | Doxorubicin-con... Placebo-contain... | 18 Years - 75 Years | SkinJect, Inc. | |
Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) | NCT04928222 | Basal Cell Carc... | Doxorubicin-con... Placebo-contain... | 18 Years - 75 Years | SkinJect, Inc. | |
A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma | NCT00833417 | Basal Cell Carc... | Vismodegib 150 ... | 18 Years - | Genentech, Inc. | |
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma | NCT04552990 | BCC BCC - Basal Cel... Basal Cell Carc... Basal Cell Canc... Superficial Bas... Nodular Basal C... | Jet injection o... Surgical excisi... Illumination Incubation | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Using MC1R Genotype to Impact Melanoma Risk Behavior | NCT03509467 | Melanoma (Skin) Squamous Cell C... Squamous Cell C... Skin Cancer Basal Cell Carc... Basal Cell Canc... | Personalized In... Standard Inform... DNA Extraction ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |